Robin Andersson
randersson.bsky.social
Robin Andersson
@randersson.bsky.social
Associate Professor at University of Copenhagen. Computational genomicist interested in gene regulation. @robin_andersson on X

https://anderssonlab.org
Reposted by Robin Andersson
Excited to share DeepCompARE + ISA - a lightweight deep learning model + efficient interpretation method, to uncover rules of TF cooperativity via genome-wide in silico motif ablations!

Preprint: www.biorxiv.org/content/10.1...
Github: github.com/anderssonlab...
Genome-wide rules of transcription factor cooperativity revealed through in silico binding site ablation
Transcription factor (TF) cooperativity plays a critical role in gene regulation. However, the underlying genomic rules remain unclear, calling for scalable methods to characterize the TF binding site...
www.biorxiv.org
June 26, 2025 at 3:03 PM
Latest from the lab! Led by @xuening-he.bsky.social, establishing a framework for interpretation of the motif syntax of regulatory elements and a quantitative model for transcription factor cooperativity. Plenty of cool stuff revealed, including TF redundancy and synergy, and their regulatory roles!
June 26, 2025 at 5:32 PM
Reposted by Robin Andersson
Symposium on ‘Enhancer Sequences’ at beautiful @collegedefrance.bsky.social in Paris, by April 11th. Open and free, no registration. Come to relax listening to facts #TherapeuticEffects #VillageGauloix Final programme below. Tell your friends! 🙏🤘
March 17, 2025 at 2:28 PM
Reposted by Robin Andersson
Job alert!

We are hiring a postdoc or PhD student focusing on
* developing computational methods to resolve gene regulation in single cells
* investigating the mechanisms and cell-type specific effects of genetic variants

PhD student: bsky.app/profile/jobr...

Postdoc: bsky.app/profile/jobr...
February 6, 2025 at 8:36 PM
Job alert!

We are hiring a postdoc or PhD student focusing on
* developing computational methods to resolve gene regulation in single cells
* investigating the mechanisms and cell-type specific effects of genetic variants

PhD student: bsky.app/profile/jobr...

Postdoc: bsky.app/profile/jobr...
February 6, 2025 at 8:36 PM
Reposted by Robin Andersson
BREAKING NEWS: CDC orders mass retraction and revision of submitted research across all science and medicine journals. Banned terms must be scrubbed.

Goes beyond MMWR +other CDC pubs. Applies to research already submitted to top medical journals.

Take a look.
open.substack.com/pub/insideme...
BREAKING NEWS: CDC orders mass retraction and revision of submitted research across all science and medicine journals. Banned terms must be scrubbed.
Any unpublished manuscript mentioning certain topics, including gender and "LGBT," must be pulled or revised.
open.substack.com
February 1, 2025 at 9:20 PM
Reposted by Robin Andersson
Together with @smandrup.bsky.social and Minna Kaikkonen we are happy to announce the 3rd Edition of the EMBO Workshop on #Enhancers and #Enhanceropathies. This time we will meet during the beautiful Danish summer (June 16-21).

Book the dates and register soon!!!

meetings.embo.org/event/25-enh...
Enhancer Mechanics and Enhanceropathies
Join us for the highly anticipated third EMBO workshop on Enhancer Mechanics and Enhanceropathies! Building on the success of our previous meetings in Santander (2021) and Marseilles (2023), this eve…
meetings.embo.org
January 31, 2025 at 2:35 PM
Reposted by Robin Andersson
Super excited to share our new study from the @jbuenrostro.bsky.social Lab in @nature.com! We developed a computational method for tracking transcription factor and nucleosome binding using single-cell ATAC-seq and deep learning.
Paper: www.nature.com/articles/s41...
Multiscale footprints reveal the organization of cis-regulatory elements - Nature
We developed PRINT, a computational method that identifies footprints of DNA–protein interactions from bulk and single-cell chromatin accessibility data across multiple scales of protein size.
www.nature.com
January 23, 2025 at 2:11 AM
Reposted by Robin Andersson
My book, An Intuitive Primer on Effective Functional Genomics Study Design, is published! I’d really appreciate it if you could help spread the word, and I’d love to hear your thoughts and feedback. I hope people will find it useful.

It’s available on Amazon: tinyurl.com/mx2hewen
January 17, 2025 at 2:30 PM
Reposted by Robin Andersson
Our ChromBPNet preprint out!

www.biorxiv.org/content/10.1...

Huge congrats to Anusri! This was quite a slog (for both of us) but we r very proud of this one! It is a long read but worth it IMHO. Methods r in the supp. materials. Bluetorial coming soon below 1/
December 25, 2024 at 11:48 PM
Reposted by Robin Andersson
We are pursuing the wrong applications for AI.
December 22, 2024 at 2:36 PM
Reposted by Robin Andersson
Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪
There are already many articles for which there is more attention on Bluesky than on other comparable micro-blogging sites, meaning the academic community and the general public have clearly adopted Bluesky as one of its core places to disseminate and discuss new research.

A Place of Joy.
December 3, 2024 at 2:10 PM
Reposted by Robin Andersson
I'd suggest this starter pack for #epigenetics and #generegulation:
go.bsky.app/TKp9YAn
plus see the description for another 3!
November 26, 2024 at 10:25 AM
Reposted by Robin Andersson
Introducing scE2G: a new model to link enhancers to target genes using single-cell data.

Excited that scE2G will enable building enhancer maps in hundreds of cell types in the human body!

Wonderful collaboration with @randersson.bsky.social @613weilin.bsky.social @mayayayas.bsky.social

Thread👇
November 25, 2024 at 11:22 PM
Reposted by Robin Andersson
Our preprint:

Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart

Multiomic atlas + human genetics = new cell types, genes, and pathways that influence heart development and disease

www.medrxiv.org/content/10.1...

Thread 👇
November 25, 2024 at 11:29 PM
Reposted by Robin Andersson
What cell types drive congenital heart defects (CHD)?

Some new answers in our latest preprint, where we explored:
1). Key cell types contributing to CHD genetics
2). Impact of noncoding variants on CHD risk

https://www.medrxiv.org/content/10.1101/2024.11.20.24317557v1
November 25, 2024 at 8:08 PM
Check out our latest work, scE2G, for mapping the target genes of enhancers from single cell data! www.biorxiv.org/content/10.1...

Amazing work led by co-first authors @mayayayas.bsky.social and @613weilin.bsky.social in a great collaboration with @jengreitz.bsky.social's lab

See 🧵 by Wei-Lin ⬇️
November 25, 2024 at 9:22 AM
Reposted by Robin Andersson
For an idea of how well fine mapping results replicate between biobanks, I would really recommend checking out this preprint from @masakanai.bsky.social
www.medrxiv.org/content/10.1...
Insights from complex trait fine-mapping across diverse populations
Despite the great success of genome-wide association studies (GWAS) in identifying genetic loci significantly associated with diseases, the vast majority of causal variants underlying disease-associat...
www.medrxiv.org
November 20, 2024 at 11:37 AM
Looking forward to #cshldata24 meeting starting tonight!

I will present #scE2G, a highly accurate model for mapping enhancer-gene regulatory interactions from single cell data. The model was developed in close collaboration with @jengreitz.bsky.social lab.

Who else is attending the meeting?
November 13, 2024 at 1:46 PM
Seeing all the excitement from fellow scientists moving from X to here reminds me of academic Twitter 10 years ago. Let’s try out this platform!

I’m a computational genomicist focused on modeling gene regulation.

#firstpost #helloworld #introduction
November 13, 2024 at 1:39 PM